Human herpesvirus 7 U21 downregulates classical and nonclassical class I major histocompatibility complex molecules from the cell surface

Journal of Virology

Volumn 84, Issue 8, 2010, Pages 3738-3751

  May, Nathan A ^a   Glosson, Nicole L ^a,b   Hudson, Amy W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN M144; PROTEIN U21; UNCLASSIFIED DRUG; VIRUS PROTEIN; CARRIER PROTEIN; HLA ANTIGEN CLASS 1; U21 GLYCOPROTEIN, HUMAN HERPESVIRUS 7;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTOMA CELL; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 7; LYSOSOME; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL LINE; IMMUNOLOGY; PATHOGENICITY; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN BINDING;

HUMAN HERPESVIRUS 7; MURINAE;

ANIMALS; CARRIER PROTEINS; CELL LINE; CELLS, CULTURED; DOWN-REGULATION; HERPESVIRUS 7, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MICE; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; VIRAL PROTEINS;

EID: 77950482035     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01782-09     Document Type: Article

References (64)

1. Ahn, K., A. Gruhler, B. Galocha, T. R. Jones, E. J. Wiertz, H. L. Ploegh, P. A. Peterson, Y. Yang, and K. Fruh. 1997. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6: 613-621. (Pubitemid 27239352)
2. Ahn, K., T. H. Meyer, S. Uebel, P. Sempe, H. Djaballah, Y. Yang, P. A. Peterson, K. Fruh, and R. Tampe. 1996. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J. 15: 3247-3255. (Pubitemid 26231930)
3. Asano, Y., S. Suga, T. Yoshikawa, T. Yazaki, and T. Uchikawa. 1995. Clinical features and viral excretion in an infant with primary human herpesvirus 7 infection. Pediatrics 95: 187-190.
4. Braud, V., E. Y. Jones, and A. McMichael. 1997. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 27: 1164-1169. (Pubitemid 27197219)
5. Caserta, M. T., M. P. McDermott, S. Dewhurst, K. Schnabel, J. A. Carnahan, L. Gilbert, G. Lathan, G. K. Lofthus, and C. B. Hall. 2004. Human herpesvirus 6 (HHV6) DNA persistence and reactivation in healthy children. J. Pediatr. 145: 478-484. (Pubitemid 39345983)
6. Cerwenka, A., and L. L. Lanier. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1: 41-49.
7. Cerwenka, A., and L. L. Lanier. 2003. NKG2D ligands: unconventional MHC class I-like molecules exploited by viruses and cancer. Tissue Antigens 61: 335-343.
8. Chalupny, N. J., A. Rein-Weston, S. Dosch, and D. Cosman. 2006. Downregulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem. Biophys. Res. Commun. 346: 175-181.
9. Chapman, T. L., and P. J. Bjorkman. 1998. Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J. Virol. 72: 460-466.
10. Cohen, G. B., R. T. Gandhi, D. M. Davis, O. Mandelboim, B. K. Chen, J. L. Strominger, and D. Baltimore. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10: 661-671.
11. Coscoy, L., and D. Ganem. 2000. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. U. S. A. 97: 8051-8056.
12. Ellis, S. A., M. S. Palmer, and A. J. McMichael. 1990. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. J. Immunol. 144: 731-735.
13. Ellis, S. A., I. L. Sargent, C. W. Redman, and A. J. McMichael. 1986. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology 59: 595-601.
14. Ferrier, P., C. Layet, D. H. Caillol, B. R. Jordan, and F. A. Lemonnier. 1985. The association between murine beta 2-microglobulin and HLA class I heavy chains results in serologically detectable conformational changes of both chains. J. Immunol. 135: 1281-1287.
15. Furman, M. H., H. L. Ploegh, and D. J. Schust. 2000. Can. viruses help us to understand and classify the MHC class I molecules at the maternal-fetal interface? Hum. Immunol. 61: 1169-1176.
16. Gewurz, B. E., E. W. Wang, D. Tortorella, D. J. Schust, and H. L. Ploegh. 2001. Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locusspecific manner. J. Virol. 75: 5197-5204.
17. Glosson, N. L., and A. W. Hudson. 2007. Human herpesvirus-6A and-6B encode viral immunoevasins that downregulate class I MHC molecules. Virology 365: 125-135.
18. Hall, C. B., M. T. Caserta, K. C. Schnabel, C. Boettrich, M. P. McDermott, G. K. Lofthus, J. A. Carnahan, and S. Dewhurst. 2004. Congenital infections with human herpesvirus 6 (HHV6) and human herpesvirus 7 (HHV7). J. Pediatr. 145: 472-477.
19. Hebert, A. M., J. Strohmaier, M. C. Whitman, T. Chen, E. Gubina, D. M. Hill, M. S. Lewis, and S. Kozlowski. 2001. Kinetics and thermodynamics of beta 2-microglobulin binding to the alpha 3 domain of major histocompatibility complex class I heavy chain. Biochemistry 40: 5233-5242.
20. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. L. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411-415.
21. Hochman, J. H., Y. Shimizu, R. DeMars, and M. Edidin. 1988. Specific associations of fluorescent beta-2-microglobulin with cell surfaces. The affinity of different H-2 and HLA antigens for beta-2-microglobulin. J. Immunol. 140: 2322-2329.
22. Hudson, A. W., D. Blom, P. M. Howley, and H. L. Ploegh. 2003. The ER- lumenal domain of the HHV-7 immunoevasin U21 directs class I MHC molecules to lysosomes. Traffic 4: 824-837.
23. Hudson, A. W., P. M. Howley, and H. L. Ploegh. 2001. A human herpesvirus 7 glycoprotein, U21, diverts major histocompatibility complex class I molecules to lysosomes. J. Virol. 75: 12347-12358.
24. Hudson, A. W., and H. L. Ploegh. 2002. The cell biology of antigen presentation. Exp. Cell Res. 272: 1-7.
25. Ishido, S., C. Wang, B. S. Lee, G. B. Cohen, and J. U. Jung. 2000. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74: 5300-5309.
26. Jones, T. R., E. J. Wiertz, L. Sun, K. N. Fish, J. A. Nelson, and H. L. Ploegh. 1996. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc. Natl. Acad. Sci. U. S. A. 93: 11327-11333.
27. Jonjic, S., M. Babic, B. Polic, and A. Krmpotic. 2008. Immune evasion of natural killer cells by viruses. Curr. Opin. Immunol. 20: 30-38.
28. Jun, Y., E. Kim, M. Jin, H. C. Sung, H. Han, D. E. Geraghty, and K. Ahn. 2000. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. J. Immunol. 164: 805-811.
29. Kavathas, P., F. H. Bach, and R. DeMars. 1980. Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc. Natl. Acad. Sci. U. S. A. 77: 4251-4255.
30. Kempf, W., V. Adams, P. Mirandola, L. Menotti, D. Di Luca, N. Wey, B. Muller, and G. Campadelli-Fiume. 1998. Persistence of human herpesvirus 7 in normal tissues detected by expression of a structural antigen. J. Infect. Dis. 178: 841-845.
31. Koch, M., V. S. Stronge, D. Shepherd, S. D. Gadola, B. Mathew, G. Ritter, A. R. Fersht, G. S. Besra, R. R. Schmidt, E. Y. Jones, and V. Cerundolo. 2005. The crystal structure of human CD1d with and without alpha-galactosylceramide. Nat. Immunol. 6: 819-826.
32. Kubota, A., S. Kubota, H. E. Farrell, N. Davis-Poynter, and F. Takei. 1999. Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144. Cell. Immunol. 191: 145-151.
33. Lanier, L. L. 1998. Follow the leader: NK cell receptors for classical and nonclassical MHC class I. Cell 92: 705-707.
34. Lee, N., D. R. Goodlett, A. Ishitani, H. Marquardt, and D. E. Geraghty. 1998. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160: 4951-4960.
35. Llano, M., M. Guma, M. Ortega, A. Angulo, and M. Lopez-Botet. 2003. Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets. Eur. J. Immunol. 33: 2744-2754.
36. McCutcheon, J. A., J. Gumperz, K. D. Smith, C. T. Lutz, and P. Parham. 1995. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J. Exp. Med. 181: 2085-2095.
37. Mostoslavsky, G., A. J. Fabian, S. Rooney, F. W. Alt, and R. C. Mulligan. 2006. Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proc. Natl. Acad. Sci. U. S. A. 103: 16406-16411.
38. Nachmani, D., N. Stern-Ginossar, R. Sarid, and O. Mandelboim. 2009. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5: 376-385.
39. Natarajan, K., A. Hicks, J. Mans, H. Robinson, R. Guan, R. A. Mariuzza, and D. H. Margulies. 2006. Crystal structure of the murine cytomegalovirus MHC-I homolog m144. J. Mol. Biol. 358: 157-171.
40. Neisig, A., C. J. Melief, and J. Neefjes. 1998. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J. Immunol. 160: 171-179.
41. Raftery, M. J., M. Hitzler, F. Winau, T. Giese, B. Plachter, S. H. Kaufmann, and G. Schonrich. 2008. Inhibition of CD1 antigen presentation by human cytomegalovirus. J. Virol. 82: 4308-4319.
42. Raftery, M. J., F. Winau, S. H. Kaufmann, U. E. Schaible, and G. Schonrich. 2006. CD1 antigen presentation by human dendritic cells as a target for herpes simplex virus immune evasion. J. Immunol. 177: 6207-6214.
43. Renukaradhya, G. J., M. A. Khan, D. Shaji, and R. R. Brutkiewicz. 2008. Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway. J. Virol. 82: 12535-12542.
44. Reusch, U., W. Muranyi, P. Lucin, H. G. Burgert, H. Hengel, and U. H. Koszinowski. 1999. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. EMBO J. 18: 1081-1091.
45. Sanchez, D. J., J. E. Gumperz, and D. Ganem. 2005. Regulation of CD1d expression and function by a herpesvirus infection. J. Clin. Invest. 115: 1369-1378.
46. Schust, D. J., D. Tortorella, J. Seebach, C. Phan, and H. L. Ploegh. 1998. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. J. Exp. Med. 188: 497-503.
47. Sernee, M. F., H. L. Ploegh, and D. J. Schust. 1998. Why certain antibodies cross-react with HLA-A and HLA-G: epitope mapping of two common MHC class I reagents. Mol. Immunol. 35: 177-188.
48. Setini, A., A. Beretta, C. De Santis, R. Meneveri, A. Martayan, M. C. Mazzilli, E. Appella, A. G. Siccardi, P. G. Natali, and P. Giacomini. 1996. Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulin. Hum. Immunol. 46: 69-81.
49. Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. J. Immunol. 142: 3320-3328.
50. Snary, D., C. J. Barnstable, W. F. Bodmer, and M. J. Crumpton. 1977. Molecular structure of human histocompatibility antigens: the HLA-C series. Eur. J. Immunol. 7: 580-585.
51. Stam, N. J., H. Spits, and H. L. Ploegh. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J. Immunol. 137: 2299-2306.
52. Storkus, W. J., D. N. Howell, R. D. Salter, J. R. Dawson, and P. Cresswell. 1987. NK susceptibility varies inversely with target cell class I HLA antigen expression. J. Immunol. 138: 1657-1659.
53. Tanaka, K., T. Kondo, S. Torigoe, S. Okada, T. Mukai, and K. Yamanishi. 1994. Human herpesvirus 7: another causal agent for roseola (exanthem subitum). J. Pediatr. 125: 1-5.
54. Tomasec, P., V. M. Braud, C. Rickards, M. B. Powell, B. P. McSharry, S. Gadola, V. Cerundolo, L. K. Borysiewicz, A. J. McMichael, and G. W. Wilkinson. 2000. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287: 1031.
55. Tomasec, P., E. C. Wang, A. J. Davison, B. Vojtesek, M. Armstrong, C. Griffin, B. P. McSharry, R. J. Morris, S. Llewellyn-Lacey, C. Rickards, A. Nomoto, C. Sinzger, and G. W. Wilkinson. 2005. Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat. Immunol. 6: 181-188.
56. Tomazin, R., N. E. van Schoot, K. Goldsmith, P. Jugovic, P. Sempe, K. Fruh, and D. C. Johnson. 1998. Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP. J. Virol. 72: 2560-2563.
57. Ulbrecht, M., S. Martinozzi, M. Grzeschik, H. Hengel, J. W. Ellwart, M. Pla, and E. H. Weiss. 2000. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol. 164: 5019-5022.
58. Ward, K. N. 1998. Infections due to the herpesvirus group in immunocompromised patients. Curr. Opin. Infect. Dis. 11: 425-430.
59. Wiertz, E. J., T. R. Jones, L. Sun, M. Bogyo, H. J. Geuze, and H. L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84: 769-779.
60. Wilkinson, G. W., P. Tomasec, R. J. Stanton, M. Armstrong, V. Prod'homme, R. Aicheler, B. P. McSharry, C. R. Rickards, D. Cochrane, S. Llewellyn-Lacey, E. C. Wang, C. A. Griffin, and A. J. Davison. 2008. Modulation of natural killer cells by human cytomegalovirus. J. Clin. Virol. 41: 206-212.
61. Wills, M. R., O. Ashiru, M. B. Reeves, G. Okecha, J. Trowsdale, P. Tomasec, G. W. Wilkinson, J. Sinclair, and J. G. Sissons. 2005. Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J. Immunol. 175: 7457-7465.
62. Yadav, M., S. Nambiar, S. P. Khoo, and H. B. Yaacob. 1997. Detection of human herpesvirus 7 in salivary glands. Arch. Oral Biol. 42: 559-567.
63. Zemmour, J., A. M. Little, D. J. Schendel, and P. Parham. 1992. The HLA-A, B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 148: 1941-1948.
64. Ziegler, H., R. Thale, P. Lucin, W. Muranyi, T. Flohr, H. Hengel, H. Farrell, W. Rawlinson, and U. H. Koszinowski. 1997. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6: 57-66.